237 related articles for article (PubMed ID: 15510595)
1. A cytokeratin- and calretinin-negative staining sarcomatoid malignant mesothelioma.
Hurtuk MG; Carbone M
Anticancer Res; 2004; 24(5B):3097-102. PubMed ID: 15510595
[TBL] [Abstract][Full Text] [Related]
2. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
[TBL] [Abstract][Full Text] [Related]
3. D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation.
Hinterberger M; Reineke T; Storz M; Weder W; Vogt P; Moch H
Mod Pathol; 2007 Feb; 20(2):248-55. PubMed ID: 17361207
[TBL] [Abstract][Full Text] [Related]
4. Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms.
Attanoos RL; Dojcinov SD; Webb R; Gibbs AR
Histopathology; 2000 Sep; 37(3):224-31. PubMed ID: 10971698
[TBL] [Abstract][Full Text] [Related]
5. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.
Lucas DR; Pass HI; Madan SK; Adsay NV; Wali A; Tabaczka P; Lonardo F
Histopathology; 2003 Mar; 42(3):270-9. PubMed ID: 12605647
[TBL] [Abstract][Full Text] [Related]
6. Calretinin is essential for mesothelioma cell growth/survival in vitro: a potential new target for malignant mesothelioma therapy?
Blum W; Schwaller B
Int J Cancer; 2013 Nov; 133(9):2077-88. PubMed ID: 23595591
[TBL] [Abstract][Full Text] [Related]
7. Spindle cell tumours of the pleura: a clinical, histological and comparative genomic hybridization analysis of 14 cases.
Knuuttila A; Jee KJ; Taskinen E; Wolff H; Knuutila S; Anttila S
Virchows Arch; 2006 Feb; 448(2):135-41. PubMed ID: 16170537
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study.
Ordóñez NG
Hum Pathol; 2004 Jun; 35(6):697-710. PubMed ID: 15188136
[TBL] [Abstract][Full Text] [Related]
9. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
[TBL] [Abstract][Full Text] [Related]
10. The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type.
Gotzos V; Vogt P; Celio MR
Pathol Res Pract; 1996 Feb; 192(2):137-47. PubMed ID: 8692714
[TBL] [Abstract][Full Text] [Related]
11. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
12. A case report of metastasis of malignant mesothelioma to the oral gingiva.
Moser S; Beer M; Damerau G; Lübbers HT; Grätz KW; Kruse AL
Head Neck Oncol; 2011 Apr; 3():21. PubMed ID: 21513537
[TBL] [Abstract][Full Text] [Related]
13. The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
Marchevsky AM; LeStang N; Hiroshima K; Pelosi G; Attanoos R; Churg A; Chirieac L; Dacic S; Husain A; Khoor A; Klebe S; Lantuejoul S; Roggli V; Vignaud JM; Weynard B; Sauter J; Henderson D; Nabeshima K; Galateau-Salle F
Hum Pathol; 2017 Sep; 67():160-168. PubMed ID: 28782639
[TBL] [Abstract][Full Text] [Related]
14. Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review.
Klebe S; Mahar A; Henderson DW; Roggli VL
Mod Pathol; 2008 Sep; 21(9):1084-94. PubMed ID: 18587319
[TBL] [Abstract][Full Text] [Related]
15. [Sarcomatoid mesothelioma--a diagnostic challenge].
Eiholm S; Meyer CN; Behrendt N
Ugeskr Laeger; 2010 Sep; 172(39):2670-1. PubMed ID: 20920392
[TBL] [Abstract][Full Text] [Related]
16. Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura.
Miettinen M; Sarlomo-Rikala M
Am J Surg Pathol; 2003 Feb; 27(2):150-8. PubMed ID: 12548160
[TBL] [Abstract][Full Text] [Related]
17. [Autopsy case of sarcomatoid malignant pleural mesothelioma].
Ogura H; Naoki K; Togashi I; Kunikane H; Okamoto H; Hida N; Narita Y; Kase M; Oosawa H; Oomori T; Watanabe K
Nihon Kokyuki Gakkai Zasshi; 2006 Oct; 44(10):689-94. PubMed ID: 17087333
[TBL] [Abstract][Full Text] [Related]
18. Malignant epithelioid mesothelioma: anti-mesothelial marker expression correlates with histological pattern.
Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
Histopathology; 2001 Dec; 39(6):584-8. PubMed ID: 11903576
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic usefulness of endobronchial ultrasound-guided transbronchial needle aspiration in a case with malignant pleural mesothelioma.
Hamamoto J; Notsute D; Tokunaga K; Sasaki J; Kojima K; Saeki S; Tanaka R; Tanaka H; Kohrogi H
Intern Med; 2010; 49(5):423-6. PubMed ID: 20190476
[TBL] [Abstract][Full Text] [Related]
20. Expression of mesothelial markers in malignant mesotheliomas: an immunohistochemical evaluation of 173 cases.
Soomro IN; Oliveira R; Ronan J; Chaudry ZR; Johnson J
J Pak Med Assoc; 2005 May; 55(5):205-9. PubMed ID: 15960287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
